We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.8B
AUM Growth
+$401M
(+2%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
872
New
34
Increased
469
Reduced
316
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$311M |
| 2 |
Chevron
CVX
|
+$78M |
| 3 |
TSMC
TSM
|
+$55.6M |
| 4 |
Core Laboratories
CLB
|
+$42.1M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$586M |
| 2 |
B
Barrick Mining
B
|
+$128M |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$86.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$74.7M |
| 5 |
Kinross Gold
KGC
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 55.1% |
| 2 | Energy | 8.94% |
| 3 | Technology | 8.27% |
| 4 | Healthcare | 6.04% |
| 5 | Financials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Incyte
INCY
$23.5B
| $17.7M | 0.09% |
208,455
-10,229
| -5% | -$821K |
|
177
Main Street Capital
MAIN
$4.97B
| $17.5M | 0.08% |
426,177
+25,968
| +6% | +$1.03M |
|
|
EXK
178
Endeavour Silver
EXK
$2.32B
| $17.4M | 0.08% |
8,508,411
-96,584
| -1% | -$197K |
|
|
ALXN
179
DELISTED
Alexion Pharmaceuticals
ALXN
| $17.2M | 0.08% |
130,965
-8,081
| -6% | -$1.04M |
|
|
EXAS
180
DELISTED
Exact Sciences
EXAS
| $16.6M | 0.08% |
140,728
-72,333
| -34% | -$7.29M |
|
181
RPC Inc
RES
$1.24B
| $16.3M | 0.08% |
2,256,464
+784,479
| +53% | +$7.45M |
|
182
Regeneron Pharmaceuticals
REGN
$68.8B
| $16.2M | 0.08% |
51,611
+3,799
| +8% | +$1.26M |
|
183
Simon Property Group
SPG
$74.5B
| $16.1M | 0.08% |
100,728
+4,207
| +4% | +$725K |
|
184
AGNC Investment
AGNC
$12.3B
| $15.8M | 0.08% |
940,190
+102,172
| +12% | +$1.78M |
|
185
BioMarin Pharmaceuticals
BMRN
$11.5B
| $15.7M | 0.08% |
182,728
-17,510
| -9% | -$1.5M |
|
|
GPL
186
DELISTED
Great Panther Mining Limited
GPL
| $15.5M | 0.07% |
1,808,349
+8,458
| +0.5% | +$68.7K |
|
187
The Mosaic Company
MOS
$7.09B
| $15.3M | 0.07% |
613,078
-199,918
| -25% | -$4.88M |
|
188
FMC
FMC
$1.42B
| $15.2M | 0.07% |
183,693
-66,466
| -27% | -$5.22M |
|
189
Sarepta Therapeutics
SRPT
$1.66B
| $14.7M | 0.07% |
96,440
-28,795
| -23% | -$3.5M |
|
|
DCUE
190
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $14.4M | 0.07% |
+139,535
| New | +$14.5M |
|
191
Qiagen
QGEN
$8.53B
| $14.4M | 0.07% |
334,043
-31,602
| -9% | -$1.31M |
|
192
DuPont de Nemours
DD
$18.6B
| $14.2M | 0.07% |
151,069
-92,455
| -38% | -$11M |
|
|
DCUD
193
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $14.1M | 0.07% |
280,002
-10,768
| -4% | -$536K |
|
194
Home Depot
HD
$332B
| $14M | 0.07% |
67,171
-3,243
| -5% | -$647K |
|
|
ONC
195
BeOne Medicines Ltd
ONC
$33.8B
| $13.9M | 0.07% |
112,493
-14,433
| -11% | -$1.83M |
|
196
Merck
MRK
$324B
| $13.9M | 0.07% |
173,679
-7,259
| -4% | -$556K |
|
|
AVTR.PRA
197
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $13.7M | 0.07% |
+207,002
| New | +$12.9M |
|
198
Prospect Capital
PSEC
$1.06B
| $13.7M | 0.07% |
2,094,710
+101,436
| +5% | +$671K |
|
|
CJ
199
DELISTED
C&J Energy Services, Inc.
CJ
| $13.4M | 0.06% |
1,141,153
+503,242
| +79% | +$6.89M |
|
200
Universal Display
OLED
$3.71B
| $13.2M | 0.06% |
70,309
+14,191
| +25% | +$2.36M |
|
Similar funds
DAM
VanEck Associates's Q2 2019 Portfolio in Review
As of Q2 2019, VanEck Associates held 872 positions worth $20.8B, up 2% from $20.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
VanEck Associates withdrew a net $819M in Q2 2019, closing 42 positions and reducing 316 holdings. Its most notable exit was Goldcorp Inc, an estimated $586M position sold in full.
By sector, the portfolio is most concentrated in Materials at 55% of assets, down from 56% a quarter earlier, followed by Energy and Technology.
Against the trend, VanEck Associates opened a new position in Royal Dutch Shell PLC ADS Class B worth $38.4M.
- VanEck Associates's largest Q2 2019 buy was Royal Dutch Shell PLC ADS Class B: 584,700 shares worth $38.4M.
- VanEck Associates added most to Newmont in Q2 2019, an estimated $311M increase.
- VanEck Associates's biggest Q2 2019 reduction was Barrick Mining, cutting an estimated $128M.
- VanEck Associates fully exited Goldcorp Inc in Q2 2019, selling an estimated $586M.
- VanEck Associates's ten largest holdings make up 35% of its $20.8B portfolio in Q2 2019.
- VanEck Associates opened 34 new positions and closed 42 in Q2 2019.
- VanEck Associates's portfolio value rose 2% quarter-over-quarter to $20.8B.
Based on VanEck Associates's 13F filing for Q2 2019, filed 7 Aug 2019.